PACAP has shown in vivo protective effects in animal models of cerebral ischemia, Parkinson’s and Alzheimer’s disease, Huntington chorea, traumatic brain and spinal cord injury, and different retinal pathologies (Reglodi et al. 2017, 2018b). The gene discussed is ADCYAP1; the disease is early-onset autosomal dominant Alzheimer disease.